Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 5
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Dyslipidemia in Transplant Patients: Which Therapy?
Iannuzzo G, Cuomo G, Di Lorenzo A, Tripaldella M, Mallardo V, Iaccarino Idelson P, Sagnelli C, Sica A, Creta M, Baltar J, Crocetto F, Bresciani A, Gentile M, Calogero A, Giallauria F. Iannuzzo G, et al. Among authors: tripaldella m. J Clin Med. 2022 Jul 14;11(14):4080. doi: 10.3390/jcm11144080. J Clin Med. 2022. PMID: 35887846 Free PMC article. Review.
Lipoprotein(a) Where Do We Stand? From the Physiopathology to Innovative Terapy.
Iannuzzo G, Tripaldella M, Mallardo V, Morgillo M, Vitelli N, Iannuzzi A, Aliberti E, Giallauria F, Tramontano A, Carluccio R, Calcaterra I, Di Minno MND, Gentile M. Iannuzzo G, et al. Among authors: tripaldella m. Biomedicines. 2021 Jul 19;9(7):838. doi: 10.3390/biomedicines9070838. Biomedicines. 2021. PMID: 34356902 Free PMC article. Review.
Association between causative mutations and response to PCSK9 inhibitor therapy in subjects with familial hypercholesterolemia: A single center real-world study.
Iannuzzo G, Buonaiuto A, Calcaterra I, Gentile M, Forte F, Tripaldella M, Di Taranto MD, Giacobbe C, Fortunato G, Rubba PO, Di Minno MND. Iannuzzo G, et al. Among authors: tripaldella m. Nutr Metab Cardiovasc Dis. 2022 Mar;32(3):684-691. doi: 10.1016/j.numecd.2021.10.025. Epub 2021 Nov 11. Nutr Metab Cardiovasc Dis. 2022. PMID: 34991937
Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet-Activating Factor and Its Precursors: A Combined Metabolomic and Lipidomic Approach.
Di Minno A, Orsini RC, Chiesa M, Cavalca V, Calcaterra I, Tripaldella M, Anesi A, Fiorelli S, Eligini S, Colombo GI, Tremoli E, Porro B, Di Minno MND. Di Minno A, et al. Among authors: tripaldella m. Biomedicines. 2021 Aug 23;9(8):1073. doi: 10.3390/biomedicines9081073. Biomedicines. 2021. PMID: 34440277 Free PMC article.
Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy.
Di Minno A, Gentile M, Iannuzzo G, Calcaterra I, Tripaldella M, Porro B, Cavalca V, Di Taranto MD, Tremoli E, Fortunato G, Rubba POF, Di Minno MND. Di Minno A, et al. Among authors: tripaldella m. Thromb Res. 2020 Oct;194:229-236. doi: 10.1016/j.thromres.2020.07.049. Epub 2020 Jul 31. Thromb Res. 2020. PMID: 33213848